Malaria victim told to pay France back €87,000

A young Frenchman who fell into a coma after contracting malaria in Africa has been told that he owes France €87,000 for his life-saving treatment and repatriation. His family has called on the French public to help foot the bill.

Malaria victim told to pay France back €87,000
Matthieu Jacquet, 28-year-old Frenchman and malaria survivor. Photo: Facebook
Matthieu Jacquet, 28, was unemployed and looking for work in eastern Africa's Malawi back in April. However, after falling violently ill, he was diagnosed with malaria and fell into a coma.
Needing urgent medical treatment and with his insurance having run out, his family was told that a medically supervised flight back to Paris would cost €250,000. 
They eventually opted for the cheaper option of a flight to the French island of Réunion in the Indian ocean, which still cost €87,000.
The man's sister, Magali, told The Local that without signing an acknowledgement of the debt, the plane would not have taken off.
“He didn't have a choice to be repatriated, he was dying,” she said. 
The trainee pastry chef recovered after spending nine days in a coma and a “three-week blackout”, only to be faced by the colossal bill which has to be paid by September 15th. 

(Photo: Facebook)
And his family is outraged. 
“I'm not disappointed with the government – I am sickened,” Matthieu's sister said. 
She added that while her brother was between jobs, he was not notified that he would not be insured by his new employers.
She also added that he wasn't taking malaria medication at the time, as he had already suffered from the illness the previous year and was deemed to have been cured.
Now, with the family unable to repay the debt, Magali has taken charge of launching an online petition in an effort to get the government to cancel the debt. It has garnered over 5,000 signatures since it was created on Tuesday.
The family has also asked the public to make donations in an effort to help chip away at the invoice. So far, around €4,000 has been raised. 
On top of this, Magali is spearheading a Facebook group in order to raise awareness, where over 1,000 people have followed to share their support.
“Another absurdity from this crap government, it disgusts me,” one follower wrote. 
The cover picture shows a black background with the words “Je Suis Matthieu”, a reference to the “Je Suis Charlie” slogan that gained worldwide recognition after the January terror attacks at the Charlie Hebdo newspaper in Paris.

(Malawi in south-eastern Africa. Photo: GoogleMaps)
But not everyone is supportive of the cause. One Facebook user, Mark Hornblower, wrote on the group's wall: 
“What a stupid idea to go to work as a chef in Malawi (…) It's lucky that he is repatriated now, safe and sound, but you can't ask taxpayers to pay for his bullshit.”
Some officials have also taken sides, some quick to note that while insurance may not be mandatory, it is recommended.
“The French mistakenly think the state will take care of everything if any problems arise,” Charlotte Hemery, communications manager at the Union for French Nationals Abroad (UFE), told Le Figaro newspaper.
“It's up to the traveller to take out insurance to help out with incidents like this.”

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.


Switzerland’s Novartis to inject $100 million into malaria drug research

Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.

Switzerland's Novartis to inject $100 million into malaria drug research
A health worker and a mother try to get down the fever of a boy with malaria in the Democratic Republic of Congo in 2017. Photo: AFP

There were some 216 million cases of malaria worldwide in 2016, an increase of five million from the year before, according to the World Health Organization.

Around 90 percent of the 445,000 of malaria-related deaths occurred in Africa, but people in southeast Asia, the eastern Mediterranean, the western Pacific and the Americas are also considered at risk.

In a bid to redress the disproportionate burden carried by African countries, Novartis said it would establish a strategy aimed at ensuring equitable pricing.

In a statement, the company also said it would “further help expand access” to treatment for children with malaria.

Novartis's announcement came as Senegal hosted a pan-African conference this week on the fight against malaria.

Deaths from malaria dropped by over 60 percent from 2000 to 2015, but because of growing resistance to available treatments and insecticides, there is a risk that the progress made so far may be slowed.

“Resistance to treatment presents the biggest threat to the incredible progress that has been made in the fight against malaria in the past 20 years,” Novartis CEO Vas Narasimhan said.

“We cannot afford to wait; this is why we are committing to advance the research and development of next-generation treatments,” he added.